Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (5)

2024

  1. Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastoma

    Neuro-Oncology Advances

  2. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib

    Oncologist, Vol. 29, Núm. 5, pp. 377-383

2023

  1. Histopathologic Changes in Congenital Corneal Stromal Dystrophy: Report of 4 Cases in 2 Families

    Applied immunohistochemistry & molecular morphology : AIMM, Vol. 31, Núm. 10, pp. 682-689

2022

  1. Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas

    Cancers, Vol. 14, Núm. 12

  2. Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma

    Therapeutic Advances in Medical Oncology, Vol. 14